The Readout Loud
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
76
321: Summit's upcoming cancer results, Recursio...
35 min
77
320: Jim Wilson's next venture, a surprise star...
37 min
78
From "Say More": What Happens When AI Decides Y...
22 min
79
319: BioMarin's executive shakeup, a GLP-1 lowe...
34 min
80
318: Drug pricing drops & psychedelics under fire
21 min
81
317: VC struggles, drug pricing negotiations, &...
28 min
82
316: The long journey to make malaria vaccines,...
34 min
83
315: UnitedHealth's doctor empire, an FDA depar...
32 min
84
314: JD Vance's biotech ties, Cassava resignati...
33 min
85
313: Biotech layoffs, founder-focused VC, & a b...
34 min
86
312: Medicare coverage for GLP-1 drugs, AI, and...
28 min
87
311: Fauci's memoir, Alnylam's tenuous trial, a...
34 min
88
310: Duchenne gene therapy setback, Alzheimer's...
38 min
89
309: Psychedelics at the FDA, ASCO recap, & Mor...
The one we recorded twice
29 min
90
308: An ASCO preview & another Duchenne trial f...
And more pronunciation difficulties
28 min
91
307: More tumult at BIO & coercive care for sic...
31 min
92
306: Live! From the STAT Breakthrough Summit West
23 min
93
305: Everything you need to know about H5N1 bir...
It's the Pulitzer episode!
31 min
94
304: Controversial brain tissue research, obesi...
Please welcome Elaine Chen to the STAT biotech team!
33 min
95
303: A new obesity startup, an acquisition gone...
Eli Lilly, Novo Nordisk, Teladoc, oh my!
31 min
96
302: Vertex's big deal, biotech's red numbers, ...
And an annoucement :(
24 min
97
301: Biotech mega-rounds, a cancer vaccine setb...
And where in the world is Damian?
31 min
98
300: What the mifepristone case means, GLP-1 sk...
Happy 300th birthday to us!
34 min
99
299: Live! From the STAT Breakthrough Summit East
With some nice "background murmering"
33 min
100
298: A dilemma in ALS, the first MASH drug, & w...
And a pie contest!
35 min